EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Dermatomyositis: Practical Guidance and Unmet Needs

Lydia Cassard iD, Noelle Seraly, Maureen Riegert, Aditi Patel, Anthony P Fernandez iD

ImmunoTargets and Therapy · 2024-03 · Volume 13 · 151-172

DOI: 10.2147/itt.s381472 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ImmunoTargets and Therapy, 2024-03. Verfasst von Lydia Cassard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dermatomyositis is a heterogeneous idiopathic inflammatory myopathy associated with various cutaneous manifestations and variable presence of myositis, interstitial lung disease, and other visceral organ involvement. An accurate diagnosis of dermatomyositis requires correlating clinical examination findings with serological and histological findings. Familiarity with pathognomonic and common cutaneous manifestations of dermatomyositis, which are highlighted here, can be especially helpful in making an accurate diagnosis. Additionally, evaluating patients for presence of myositis-specific autoantibodies can further support or refute a dermatomyositis diagnosis. When present, myositis-specific autoantibodies can also help guide workups for various dermatomyositis-associated manifestations, as each is associated with relatively distinct clinical characteristics. Evaluating patients for various systemic manifestations often relies on expert opinion recommendations; however, societal guideline statements concerning the evaluation of some manifestations have recently been described. Although malignancy-associated dermatomyositis is a well-accepted subtype, there is limited evidence to support extensive malignancy screening has a favorable benefit-risk ratio in most dermatomyositis patients. However, recent research has uncovered novel associations between dermatomyositis and malignancy, suggesting the possibility of identifying high-risk subsets of dermatomyositis patients in whom malignancy screening may have a high value. Treatment for dermatomyositis has remained largely unchanged over the past several decades. Although many dermatomyositis patients can be effectively treated with current options, either as monotherapy or with combination regimens, there is a need for more targeted and effective DM therapies, in general, and for MDA5(+) dermatomyositis-associated rapidly progressive interstitial lung disease. Fortunately, significant current and emerging research activities evaluating various novel medications for dermatomyositis provide hope for exciting future advances in patients with this intriguing immune-mediated disease.

Schlagwörter

Stichwörter der Autor:innen

MDA-5autoantibodyidiopathic inflammatory myopathymalignancymyositistreatment

Autor:innen und Institutionen

  • Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA.
  • Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Dermatology, Rush University, Chicago, IL, USA.
  • Department of Rheumatology, Cleveland Clinic, Cleveland, OH, USA.
  • Departments of Dermatology and Pathology, Cleveland Clinic, Cleveland, OH, USA.

ORCID-Profile: Lydia Cassard, Anthony P Fernandez

Zitieren

APA

Cassard, L., Seraly, N., Riegert, M., Patel, A., & Fernandez, A. P. (2024). Dermatomyositis: Practical Guidance and Unmet Needs. ImmunoTargets and Therapy, Volume 13, 151-172. https://doi.org/10.2147/itt.s381472

Vancouver

Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP. Dermatomyositis: Practical Guidance and Unmet Needs. ImmunoTargets and Therapy. 2024;Volume 13:151-172. doi:10.2147/itt.s381472

BibTeX
@article{Cassard2024,
  author = {Cassard, Lydia and Seraly, Noelle and Riegert, Maureen and Patel, Aditi and Fernandez, Anthony P},
  title = {Dermatomyositis: Practical Guidance and Unmet Needs},
  journal = {ImmunoTargets and Therapy},
  year = {2024},
  volume = {Volume 13},
  pages = {151--172},
  doi = {10.2147/itt.s381472}
}
Kostenlos starten →